These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Argon laser trabecular surgery as an alternative to carbonic anhydrase therapy.
    Author: Fink AI, Jordan AJ, Bunke A, Fong D.
    Journal: Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():125-8. PubMed ID: 6963043.
    Abstract:
    Thirty-four eyes (25 patients) with diagnosed chronic open angle glaucoma on maximal medical therapy were studied to determine whether argon laser trabecular surgery was a desirable alternative to carbonic anhydrase therapy. Ninety-four per cent of patients responded favourably to argon laser trabecular surgery as an alternative to carbonic anhydrase therapy. The average pressure drop was 9.9 mm Hg. Interestingly, there was a mean drop of 4.2 mm Hg in the contralateral eye. There was minimal, if any, iris response although there was a small but probably not clinically significant decrease in corneal endothelial cell count. Blanching of the trabecular wall was used as the endpoint to help minimize post-laser pressure rise. Blacks and aphakic patients responded satisfactorily. Laser surgery is best reserved for those patients with a pretreatment intraocular pressure no higher than the 30 to 35 mm Hg level. Trabeculectomy, in spite of its known complications, offers a better prognosis in those cases where the pretreatment pressure exceeds the 30 to 35 mm Hg level.
    [Abstract] [Full Text] [Related] [New Search]